World Health Organization, the World Bank, the United Nations Development Programme, and the Commission of the European Communities.

While there are historical precedents for aspects of the proposed Malaria Vaccine Development Board, none completely covers all of the facets described above. Some examples of precedents that may be examined for relevance to elements of the board include the 1941 Commission on Influenza of the Armed Forces Epidemiology Board, the National Task Force on AIDS Drug Development, and the National Foundation for Infantile Paralysis.

  • The board should commission independent market analyses to assess potential global markets—both private and public—for each of the types of malaria vaccine. These analyses should be conducted by country or region, both in the industrialized and developing world, and findings made available to the global vaccine industry.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement